Nicorette QuickMist Now Approved for Vaping Dependence: What Pharmacies Need to Know

The Therapeutic Goods Administration (TGA) has recently expanded the approval of Nicorette QuickMist, allowing it to be used not only for smoking cessation but also for vaping dependence. This marks a significant step forward in supporting Australians looking to reduce or quit nicotine altogether.

Why This Matters for Pharmacies

Vaping has become increasingly common, with approximately 1.7 million Australians vaping regularly. Research shows that a large proportion of vapers—around three in four—intend to quit or cut down within months. Until now, options for clinically approved vaping cessation therapies were limited.

With this TGA approval, pharmacies can now provide patients with a fast-acting, evidence-based tool specifically for vaping dependence. This reinforces the role of pharmacists as accessible healthcare professionals in the journey to reduce nicotine-related harm.

How Nicorette QuickMist Supports Patients

Nicorette QuickMist delivers a fast, controlled dose of nicotine to the mouth, helping to manage cravings and withdrawal symptoms. Clinical trials demonstrated that:

• 80% of users experienced at least a 50% reduction in cravings after a single spray.

• The fast-acting nature of the spray helps patients cope with intense early withdrawal periods.

Pharmacies can now integrate QuickMist into personalized quit plans, alongside behavioural strategies, lifestyle changes, and support programs.

Practical Tips for Pharmacy Teams

1. Educate Patients: Explain how QuickMist works and its suitability for vaping dependence.

2. Individualize Advice: Assess nicotine usage, triggers, and patient preferences to recommend appropriate dosing.

3. Combine with Support: Encourage patients to join quit programs or track progress with behavioural strategies for better long-term outcomes.

4. Reassure About Safety: Highlight that QuickMist is a TGA-approved, clinically tested therapy.

Key Takeaway

The TGA’s expanded approval of Nicorette QuickMist offers pharmacies a new, effective option to support patients quitting vaping, strengthening the trusted role of pharmacists in nicotine dependence management. By providing guidance, education, and access to approved therapies, pharmacies can help patients take meaningful steps toward a smoke- and vape-free life.